Neurosense Therapeuti -CW23NRSNWPreferred / convertible
13F holders, Q4 2025 (December 31)3holders +1
0new positions
0sold out
$0.34avg. 13F price*
At the end of Q4 2025, 3 institutions reported holding Neurosense Therapeuti -CW23 (NRSNW) in their 13F filings, up 1 from Q3 2025. 0 opened new positions and 0 sold out. The largest holders were Empery Asset Management, LP ($36K), Clear Street Group Inc. ($20K) and UBS Group AG ($291).
- Company
- Neurosense Therapeuti -CW23
- CUSIP
- M74240116
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q3 2025 → Q4 2025: 417 shares sold, net −417 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Empery Asset Management, LP | — | — | 100,402 | $36K |
| Clear Street Group Inc. | — | Reduce -0.5% | 63,385 | $20K |
| UBS Group AG | — | Reduce -9.1% | 1,163 | $291 |
"% of holder's portfolio" is NRSNW's weight in each manager's 13F, not the share of Neurosense Therapeuti -CW23 the manager owns.